94340 ⎘
Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems; Dibenzazepines; Hydrogenated dibenzazepines Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
Sub-classes:Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
#2MATERIALS FOR ELECTRONIC DEVICES
#3Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides
#4NOVEL CRYSTALLINE FORM OF ESLICARBAZEPINE
#5BLUE FLUORESCENT EMITTERS
#6Selective inhibitors of constitutive androstane receptor
#7Biocatalytic process for preparing eslicarbazepine and analogs thereof
#8Asymmetric catalytic reduction of oxcarbazepine
#9Compound, light emitting material, and organic light emitting device
#10Biocatalytic process for preparing eslicarbazepine and analogs thereof
#11Biocatalytic process for preparing eslicarbazepine and analogs thereof
#12Lisofylline analogs and methods for use
#13Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#14Process for the preparation of (S)-(+)- or (R)-(-)-10-hydroxy dihydrodibenz[B,F]azepines by enantioselective reduction of 10,11-dihydro-10-OXO-5H-dibenz[B,F]azepines and polymorphs thereof
#15Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor
#16Metal complexes with organic ligands and use thereof in OLEDs
#17Asymmetric catalytic reduction of oxcarbazepine
#18MODULATING IRES-MEDIATED TRANSLATION
#19INHIBITORS OF HISTONE DEACETYLASE
#20Process for the preparation of oxcarbazepine
#21Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation
#22Novel organic electroluminescent compounds and organic electroluminescent device using the same
#23Novel organic electroluminescent compounds and organic electroluminescent device using the same
#24Asymmetric catalytic reduction of oxcarbazepine
#25Materials for organic electroluminescent devices
#26Method for chiral inversion of (S)-(+)-and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
#27Systems and Methods for the Generation of Crystalline Polymorphs
#28Process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide
#29COMPOUNDS TO TREAT AMYLOIDOSIS AND PREVENT DEATH OF BETA-CELLS IN TYPE 2 DIABETES MELLITUS
#30Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#31Lisofylline analogs and methods for use
#32Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide
#33Anthrancene derivative compound and organic light-emitting device including the same
#34Oxacarbazepine film-coated tablets
#35Process for preparing oxcarbazepine
#36Aralkyl ester soft drugs
#37Oxacarbazepine film-coated tablets
#38Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
#39Method and compositions for temporarily incapacitating subjects
#401-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
#41Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
#42Tricyclic compounds with antiviral activity